These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38697036)

  • 41. Comparative Effectiveness of Dual Antiplatelet Therapy With Aspirin and Clopidogrel Versus Aspirin Monotherapy in Mild-to-Moderate Acute Ischemic Stroke According to the Risk of Recurrent Stroke: An Analysis of 15 000 Patients From a Nationwide, Multicenter Registry.
    Lee HL; Kim JT; Lee JS; Park MS; Choi KH; Cho KH; Kim BJ; Park JM; Kang K; Lee SJ; Kim JG; Cha JK; Kim DH; Park TH; Park SS; Lee KB; Lee J; Hong KS; Cho YJ; Park HK; Lee BC; Yu KH; Sun Oh M; Kim DE; Ryu WS; Choi JC; Kwon JH; Kim WJ; Shin DI; Sohn SI; Hong JH; Lee J; Bae HJ
    Circ Cardiovasc Qual Outcomes; 2020 Nov; 13(11):e006474. PubMed ID: 33201737
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China.
    Bao XY; Duan L; Li DS; Yang WZ; Sun WJ; Zhang ZS; Zong R; Han C
    Cerebrovasc Dis; 2012; 34(4):305-13. PubMed ID: 23146868
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Angiographic and Hemodynamic Features in Asymptomatic Hemispheres of Patients With Moyamoya Disease.
    Sun H; Li W; Xia C; Ren Y; Ma L; Xiao A; You C; Liu Y; Tian R
    Stroke; 2022 Jan; 53(1):210-217. PubMed ID: 34547926
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk factors for stroke recurrence in patients with hemorrhagic stroke.
    Wong YS; Tsai CF; Ong CT
    Sci Rep; 2022 Oct; 12(1):17151. PubMed ID: 36229641
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Moyamoya disease. Report of three cases in Brazilian patients.
    Franco CM; Fukujima MM; de Oliveira Rde M; Gabbai AA
    Arq Neuropsiquiatr; 1999 Jun; 57(2B):371-6. PubMed ID: 10450341
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Direct versus indirect bypasses for adult ischemic-type moyamoya disease: a propensity score-matched analysis.
    Deng X; Gao F; Zhang D; Zhang Y; Wang R; Wang S; Cao Y; Zhao Y; Pan Y; Liu X; Zhang Q; Zhao J
    J Neurosurg; 2018 Jun; 128(6):1785-1791. PubMed ID: 28799875
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome.
    Bala MM; Celinska-Lowenhoff M; Szot W; Padjas A; Kaczmarczyk M; Swierz MJ; Undas A
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012169. PubMed ID: 28968483
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of Clinical and Radiological Features of Quasi-Moyamoya Disease among European Caucasians Including Surgical Treatment and Outcome.
    Acker G; Goerdes S; Schmiedek P; Czabanka M; Vajkoczy P
    Cerebrovasc Dis; 2016; 42(5-6):464-475. PubMed ID: 27578358
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia.
    Kim T; Oh CW; Kwon OK; Hwang G; Kim JE; Kang HS; Cho WS; Bang JS
    J Neurosurg; 2016 Jun; 124(6):1788-93. PubMed ID: 26636391
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and Safety of Antiplatelet Agents for Adult Patients With Ischemic Moyamoya Disease.
    Ye F; Li J; Wang T; Lan K; Li H; Yin H; Guo T; Zhang X; Yang T; Liang J; Wu X; Li Q; Sheng W
    Front Neurol; 2020; 11():608000. PubMed ID: 33519687
    [No Abstract]   [Full Text] [Related]  

  • 52. Late (5-20 years) outcomes after STA-MCA anastomosis and encephalo-duro-myo-arterio-pericranial synangiosis in patients with moyamoya disease.
    Kuroda S; Nakayama N; Yamamoto S; Kashiwazaki D; Uchino H; Saito H; Hori E; Akioka N; Kuwayama N; Houkin K
    J Neurosurg; 2021 Mar; 134(3):909-916. PubMed ID: 32168480
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel system for evaluating collateralization of the external carotid artery after cerebral revascularization in moyamoya disease.
    Li W; Zhao M; Liu X; Wang P; Zhu H; Zhang Q; Zhu C; Zhang Q; Zhao J; Zhang Y
    J Neurosurg; 2024 Jun; 140(6):1707-1715. PubMed ID: 38157529
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Moyamoya disease in pregnancy: a case series and review of management options.
    Ma JC; Burlingame JM
    Hawaii Med J; 2011 Aug; 70(8):161-3. PubMed ID: 21886307
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Trends of Antiplatelet Therapy for the Management of Moyamoya Disease in Japan: Results of a Nationwide Survey.
    Oki K; Katsumata M; Izawa Y; Takahashi S; Suzuki N; Houkin K;
    J Stroke Cerebrovasc Dis; 2018 Dec; 27(12):3605-3612. PubMed ID: 30220629
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of moyamoya vasculopathy with autoimmune disease: a systematic review and pooled analysis.
    Singh R; Bauman MMJ; Seas A; Harrison DJ; Pennington Z; Brown NJ; Gendreau J; Rahmani R; Ellens N; Catapano J; Lawton MT
    Neurosurg Rev; 2023 Sep; 46(1):220. PubMed ID: 37658996
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antiplatelet drugs for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis.
    Del Giovane C; Boncoraglio GB; Bertù L; Banzi R; Tramacere I
    BMC Neurol; 2021 Aug; 21(1):319. PubMed ID: 34399713
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Symptomatic Moyamoya disease: clinical features and outcome after indirect bypass surgery in four French adults.
    Derex L; Doumbé J; Kouamé-Assouan AE; Pelissou-Guyotat I; Morel C; Hermier M; Nighoghossian N; Trouillas P
    J Neurol Sci; 2010 Jan; 288(1-2):92-5. PubMed ID: 19840882
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Encephaloduroarteriosynangiosis with Dural Inversion for Moyamoya Disease in a Pediatric and Adult Population-a Single-Center 20-Year Experience.
    Goren O; Hendrix P; Peled A; Kimchi G; Zauberman J; Griessenauer C; Feldman Z
    World Neurosurg; 2021 May; 149():e16-e21. PubMed ID: 33647488
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Direct Bypass Surgery Vs. Combined Bypass Surgery for Hemorrhagic Moyamoya Disease: A Comparison of Angiographic Outcomes.
    Zhao Y; Yu S; Lu J; Yu L; Li J; Zhang Y; Zhang D; Wang R; Zhao Y
    Front Neurol; 2018; 9():1121. PubMed ID: 30619072
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.